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SUMMARY
Hypothalamic–pituitary–adrenocortical (HPA) regulation in adults is inﬂuenced by early
psychosocial adversity, but the role of infectious disease history is poorly understood. We studied
the association between cumulative pathogen burden and cortisol proﬁle over the day in a sample
of 317 healthy men and women aged 51–72 years. Cumulative pathogen burden was deﬁned
as positive serostatus for Chlamydia pneumoniae, cytomegalovirus (CMV) and herpes simplex
virus 1 (HSV-1). Salivary cortisol was sampled repeatedly over the day. The cortisol slope was
deﬁned as the decrease across the day and evening. Age, gender, grade of employment, body mass
index, smoking status, self-rated health, cardiovascular medication, depressed mood and time of
waking were included as covariates. The pathogen burden averaged 1.76 (S.D.=0.92). The cortisol
slope was inversely associated with pathogen burden after controlling for covariates. When
individual pathogens were studied, only CMV was associated with ﬂatter cortisol rhythms in
isolation. We conclude that pathogen burden is independently associated with ﬂatter cortisol
slopes over the day, and may contribute to disturbed neuroendocrine regulation.
Key words: Cortisol awakening response, Chlamydia pneumoniae, cytomegalovirus,
herpes simplex virus 1, psychosocial adversity.
INTRODUCTION
There is abundant evidence that early childhood
adversity inﬂuences adult health outcomes, with fac-
tors such as low childhood socioeconomic status
(SES), poverty, and poor or overcrowded housing
being associated with increased risk of cardiovascular,
respiratory and psychiatric illness [1–3]. These eﬀects
may be mediated in part through stress processes,
since childhood abuse, family discord and negative
life events increase risk for later ill health [4–6], and
tend to cluster in children of lower SES [7]. Childhood
stressors also impact on biological processes relevant
to adult disease risk [8, 9]. Extensive research both in
animals and humans has documented the impact of
early psychosocial adversity on neuroendocrine func-
tion in adult life, with eﬀects on cortisol regulation
and stress reactivity [10, 11]. Childhood SES is associ-
ated with aberrant proﬁles of cortisol over the day
independently of adult SES [12]. Stress-induced
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a key process linking early life experience with adult
risk of physical disease and psychopathology [13–15].
Cortisol has a pronounced diurnal rhythm, with high
levels early in the morning, declining throughout the
day to a nadir in the late evening and early hours of
sleep [16]. The full diurnal proﬁle requires repeated
blood sampling, usually in clinical or laboratory
settings, but the introduction of salivary cortisol
measurements has permitted the proﬁle over waking
hours to be assessed in large samples in everyday life
[17]. Diﬀerent aspects of the diurnal proﬁle appear
to be associated with SES and other psychosocial
factors, notably the cortisol awakening response
(CAR; the rise over the ﬁrst 30–45 min after waking),
the overall cortisol output over the day, and the slope
of cortisol decline over the day [17, 18].
Another pathway through which early life ad-
versity may inﬂuence adult disease risk is ex-
posure to common pathogens. Thus seropositivity
for cytomegalovirus (CMV), Chlamydia pneumoniae
(C. pneumoniae), herpes simplex virus 1 (HSV-1), and
Helicobacter pylori is greater in individuals of low
SES deﬁned by education, poverty or occupational
status, and with household crowding [19–25]. These
pathogens are typically acquired in childhood [26],
when they may or may not be symptomatic [27–29].
Reactivation of speciﬁc pathogens such as CMV and
HSV-1 may be relevant to disease risk and cognitive
decline in older age [30, 31]. In addition, cumulative
pathogen burden, deﬁned by positive serostatus for a
range of pathogens, has been associated with cardio-
vascular risk factors and with coronary heart disease
(CHD) in case-control and longitudinal cohort
studies [32–35].
The relationship between pathogen burden and
cortisol proﬁle in adults has not been extensively
investigated. Animal studies have demonstrated that
early-life exposure to endotoxin alters later-life
hypothalamic–pituitary–adrenocortical (HPA) func-
tion, with raised corticosterone output over the day
[36]. Glucocorticoids are known to enhance the
growth of C. pneumoniae in cell cultures [37] and the
replication of human CMV in embryonic cells [38].
Additionally, early childhood exposure to upper res-
piratory infection was negatively correlated with cor-
tisol sampled in the clinic and in the late evening
in the Barry Caerphilly Growth cohort [39]. In this
study, we hypothesized that cumulative pathogen
burden, deﬁned by positive serostatus for C. pneumo-
niae, CMV and HSV-1, inﬂuences cortisol regulation
in adult life. We measured salivary cortisol over the
day and evening, speciﬁcally focusing on total cortisol
output, the CAR, and the slope of cortisol decline
over the day. A blunted CAR has been associated
with cardiovascular risk factors [40], while a ﬂattened
cortisol proﬁle over the day is related to subclinical
coronary artery disease [41] and abdominal adiposity
[42]. Other factors such as age, gender, low SES, body
mass, smoking, depression, health status, and time of
waking have been related to cortisol proﬁles over the
day, and were therefore taken into account in the
analyses.
METHODS
Participants
Data were analysed from 361 members (237 men, 124
women) aged 51–72 years from the Whitehall II epi-
demiological cohort [43]. Data were collected from
consecutive attendees at a medical screening session
where we completed assessments of serostatus for
C. pneumoniae, CMV, and HSV-1, as detailed else-
where [20]. All participants were in good health, with
no indications of current infection. In total, 378 par-
ticipants carried out salivary cortisol assessments
over the day and evening, of whom 17 were excluded
because they were taking either oral or inhaled cor-
ticosteroid medication. The individuals taking part
in this substudy did not diﬀer from the remaining
healthy participants in the medical screening in terms
of age, gender and SES. None of the participants were
shift-workers. The study was approved by the Uni-
versity College London/University College London
Hospitals Medical Ethics Committee, and all partici-
pants gave signed consent.
MEASURES
Participants underwent a physical examination during
which fasting blood samples were obtained. Height
and weight were measured, and body mass index
(BMI) was computed. Current or most recent occu-
pational grade in the civil service was used to index
SES, and participants were divided into higher, in-
termediate and lower grade groups. Self-rated health
was measured with a single item (‘In general, would
you say your health is: excellent, very good, good,
fair, or poor’) that has consistentlybeen shown to pre-
dict adverse health outcomes [44]. Depressed mood
was measured using the Center for Epidemiologic
Cortisol and infectious burden 1817Studies Depression (CES-D) scale. Current medi-
cation was also assessed.
Salivary sampling with salivettes (Sarstedt, UK)
was explained and practised during the health screen-
ing. Participants were instructed to collect saliva im-
mediately after waking, 30 min later, and then at
2½ h, 8 h and 12 h after waking, with a ﬁnal sample
being obtained just before bedtime. They were in-
structed to record the time of sample collection, take
samples as soon as they woke, avoid caﬀeine and
acidic drinks in the ﬁrst 30 min, and not brush teeth
or eat or drink anything for 15 min before a sample
collection. Time of waking was recorded along with
the actual times the saliva samples were collected.
Participants stored salivettes in domestic refrigerators
before posting them back to the laboratory. Saliva
sampling took place within 7–10 days of the collection
of blood samples used for the analysis of sero-
positivity.
Laboratory methods
Serostatus for C. pneumoniae, CMV, and HSV-1
was assayed at Umea ˚ University using methods de-
scribed previously [45]. Brieﬂy, C. pneumoniae IgG
was measured with the Chlamydia microtitre indirect
immunoﬂuorescence test (Focus Technologies, USA)
using a serum dilution of 1/16. Each serum was tested
against antigen from C. pneumoniae and a control
antigen. Two control sera were used, one seropositive
and one seronegative. The results were read manually
by ﬂuorescent microscopy by two independent in-
vestigators and sera with a speciﬁc apple green ﬂuor-
escence were considered seropositive. Sera reacting
with the control antigen were not possible to interpret
and therefore excluded from the analyses. All pro-
cedures and interpretation were performed according
to the manufacturer’s instructions. The antigen for
the CMV IgG ELISA was derived from CMV-strain
Ad169 cultured in human ﬁbroblasts. The antibody
activity was expressed in arbitrary units (AU); a value
of o10 AU was considered positive for presence of
IgG and <5 AU as negative. A grey zone area was
deﬁned in the range between 5–9 AU, but participants
who fell into this range were classiﬁed conservatively
as seronegative. The antigen for the HSV-1 IgG
ELISA was a local HSV-1 strain cultured in GMK-
cells. Both tests followed the protocols and materials
used for clinical tests accredited by SWEDAC
(Swedish Board for Accreditation and Conﬁrma-
tory Assessment), and external international quality
assurance programmes from Labquality and the UK
National External Quality Assessment Service vali-
date the tests several times a year. The sensitivity of
detecting these latent viral infections is estimated
to be almost 100%. The speciﬁcity is also very high
since each serum sample is controlled for unspeciﬁc
reactivity by a control antigen. The high and low
reacting control sera used have been tested at two in-
dependent accredited laboratories according to stan-
dard accreditation regulations.
Salivary samples were sent to the Technical
University Dresden for the analysis of cortisol. The
salivettes were centrifuged at 3000 rpm for 5 min,
resulting in a clear supernatant of low viscosity.
Salivary cortisol levels were measured using a com-
mercial immunoassay with chemiluminescence detec-
tion (CLIA; IBL-Hamburg, Germany). The lower
limit of the assay was 0.44 nmol/l, and intra- and
inter-assay coeﬃcients of variance were <8%.
Statistical analysis
Delays between waking in the morning and taking
the ‘waking’ cortisol sample can lead to inaccurate
waking values and a diminished CAR [46]. We ex-
cluded 44 individuals who reported a delay of more
than 15 min between waking and taking sample 1,
leaving 317 in the analysis. There were no diﬀerences
in age, gender, seropositivity, self-rated health or
other factors between those who were included and
excluded from the ﬁnal analysis. Cumulative patho-
gen burden was deﬁned as the number of pathogens
(C. pneumoniae, CMV, HSV-1) for which the indi-
vidual was seropositive, so could range from 0 to 3.
The associations between pathogen burden and age,
gender, SES (grade of employment), BMI, smoking
status, self-rated health, depression and time of
waking were assessed using analysis of variance
for continuous measures and x
2 tests and logistic re-
gression for categorical variables. The most common
medications were related to cardiovascular health,
including antihypertensives and statins. The use of
cardiovascular medication was therefore included as
an additional covariate. Total cortisol output over
the day was computed using area under the curve
methods involving all six samples [47]. The slope or
rate of decline in cortisol over the day was computed
by calculating regression slopes across all data-points
except the 30-min post-waking sample (sample 2), and
was expressed as nmol/l per h. The CAR was assessed
as the diﬀerence between samples 1 and 2. The cortisol
1818 A. Steptoe and othersoutput, cortisol slope over the day and CAR were
normally distributed, while levels on waking and bed-
time were skewed, and therefore log-transformed be-
fore analysis. The relationship of cortisol with burden
of infection was assessed with analysis of covariance,
adjusting for age, gender, SES, BMI, smoking status,
self-rated health, depression and time of waking.
Results are presented as means¡standard deviations.
RESULTS
The 317 participants in the analysis included 205
men and 112 women aged 61.0¡5.7 years. Serological
status for the three pathogens is summarized in
Table 1. The pathogen burden was 0 in 9.8%, 1 in
27.8%, 2 in 39.1% and 3 in 23.3%, with a mean of
1.76¡0.92. Pathogen burden did not diﬀer between
men and women, but was positively related to age
(P=0.004). As previously described, participants of
lower SES tended to have a greater pathogen burden
(P=0.016) [20]. Pathogen burden was positively as-
sociated with BMI, but was not related to smoking,
self-rated health, cardiovascular medication, de-
pressed mood or time of waking in the morning
(Table 2).
Figure 1 illustrates the proﬁle of salivary cortisol
over the study. Participants woke at 6:41 on average,
and took the 30-min post-waking sample at 7:12¡
56 min. Subsequent measures were taken at the
expected intervals. Cortisol increased by 6.88¡
10.4 nmol/l between waking and 30 min later, falling
over the remainder of the day. Cortisol output over
the day averaged 7.87¡2.87 nmol/l, while the rate
of cortisol decline over the day averaged 1.204¡
0.89 nmol/l per h.
There was no relationship between pathogen bur-
den and total cortisol output over the day (Table 3).
This was also true when the three individual patho-
gens were tested. However, there was a signiﬁcant
linear association between pathogen burden and cor-
tisol decline over the day after adjustment for age,
gender, grade of employment, BMI, smoking status,
self-rated health, cardiovascular medication, de-
pression and time of waking (P=0.010). As can be
seen in Figure 2, the rate of cortisol decrease over the
day was greatest in participants with zero pathogen
burden, and least in those with the highest pathogen
burden. This indicates that the cortisol rhythm over
the day was ﬂatter in participants with greater
pathogen burden, independently of covariates associ-
ated with pathogen exposure and cortisol output.
When we analysed relationships with individual
pathogens, a ﬂatter cortisol slope was associated with
seropositivity for CMV (P<0.001), but not the other
pathogens in isolation. Results were unchanged when
waist/hip ratio was included as an additional co-
variate.
The ﬂatter cortisol decline over the day in partici-
pants with a greater pathogen burden was driven
primarily by diﬀerences in cortisol levels on waking.
Separate analysis of the waking values showed a
signiﬁcant association with pathogen burden after
adjustment for age, gender, SES, BMI, smoking
status, self-rated health, cardiovascular medication,
depression and time of waking (P=0.031). Cortisol
levels on waking were higher in participants with zero
pathogen burden scores. By contrast, pathogen bur-
den was not related to cortisol at bedtime (P=0.63),
although values were lowest in participants with zero
pathogen burden.
There was no association between pathogen burden
and CAR (P=0.58). The CAR averaged 6.76¡10.1,
7.34¡10.3, 6.18¡10.1a n d8 .58¡11.0 nmol/l in par-
ticipants with burden scores of 0, 1, 2 and 3 respect-
ively, after adjustment for covariates.
DISCUSSION
Cumulative pathogen burden has been postulated to
be a risk factor for CHD, contributing to athero-
sclerosis [20, 32, 33]. Exposure to pathogens is greater
in lower SES groups and in individuals who experi-
ence poverty and adversity in early life. Since early
stress and adversity are related to HPA regulation,
we reasoned that older adults with greater pathogen
burden scores might show disturbances of cortisol
output. It should be emphasized that these analyses
of associations between cortisol output over the day
Table 1. Pathogen burden
Pathogen
Serostatus, N (%)
Positive Negative
Chlamydia pneumoniae
(n=317)
200 (64.7%) 109 (35.3%)
Cytomegalovirus
(n=315)
165 (52.4%) 150 (47.6%)
Herpes simplex virus 1
(n=317)
193 (60.9%) 124 (39.1%)
Total pathogen burden
(n=317) mean (S.D.)
1.76 (0.92)
Cortisol and infectious burden 1819and cumulative pathogen burden are preliminary,
since only three pathogens contributed to the cumu-
lative burden index, and salivary cortisol was
measured over only a single day. Nevertheless, we
found that pathogen burden was associated with a
ﬂatter cortisol rhythm over the day, independently of
factors that potentially inﬂuence cortisol including
age, gender, current SES, smoking, BMI, depression,
self-rated health, and time of waking in the morning.
The ﬂatter cortisol slope was driven primarily by
lower cortisol values on waking in participants with
greater pathogen burden, rather than raised evening
values. Flatter cortisol slopes appear to be associated
with increased health risk, and have been related in
other studies to coronary disease and abdominal adi-
posity [41, 42]. A longitudinal study of patients with
breast cancer found that ﬂatter cortisol slopes pre-
dicted early mortality, independently of covariates
[48]. Additionally, ﬂatter cortisol slopes are associated
with some aspects of psychological stress and coping;
e.g. men and women with marital problems have
Table 2. Participant characteristics associated with pathogen burden
Pathogen burden
P trend 0( n=31) 1 (n=88) 2 (n=124) 3 (n=74)
Age (years) 59.1( 5 .3) 60.5( 5 .5) 60.9( 6 .0) 62.5( 5 .2) 0.004
Gender (male), n (%) 18 (58.1%) 61 (69.3%) 75 (60.5%) 51 (68.9%) 0.69
Grade of employment
Higher 6 (20.0%) 29 (33.0%) 28 (22.6%) 14 (18.9%) 0.016
Intermediate 16 (53.3%) 47 (53.4%) 59 (47.6%) 36 (48.6%)
Lower 8 (26.7%) 12 (13.6%) 37 (29.8%) 24 (32.4%)
Body mass index 26.4( 5 .8) 25.4( 4 .1) 26.5( 4 .3) 27.9( 4 .2) 0.032
Current smokers, n (%) 2 (6.5%) 8(9.2%) 11(8.9%) 8 (10.8%) 0.51
Self-rated health (fair or poor), n (%) 6 (21.4%) 7(8.2%) 14 (12.2%) 10 (14.7%) 0.43
Cardiovascular medication, n (%) 3 (9.7%) 5(5.7%) 15 (12.1%) 12 (16.2%) 0.068
CES-D depression 8.80 (9.3) 8.73 (8.2) 8.52 (7.8) 8.14 (7.9) 0.95
Time of waking in the morning (h:min) 6:33 (38) 6:42 (52) 6:42 (59) 6:39 (57) 0.96
Results expressed as means (standard deviation) and n (percent).
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Fig. 1. Mean salivary cortisol at the six assessment points
over the day. Error bars are standard error of the mean
(S.E.M.).
Table 3. Salivary cortisol in relation to pathogen burden
Time (h:min)
Pathogen burden
0123
Waking (6:41¡0:55) 21.29¡1.66 18.29¡0.89 17.95¡76 17.26¡1.01
Wake+30 min (7:13¡0:56) 28.36¡2.11 25.59¡1.13 23.93¡0.96 25.63¡1.30
Wake+2.5 h (9:17¡0:58) 7.79¡1.07 10.75¡0.60 9.74¡0.51 10.47¡0.66
Wake+8 h (14:51¡1:05) 5.99¡0.84 6.73¡0.47 6.78¡0.40 7.59¡0.52
Wake+12 h (18:52¡1:04) 4.34¡0.63 3.60¡0.36 3.19¡0.30 3.44¡0.39
Bedtime (23:10¡0:57) 2.47¡0.61 3.12¡0.34 2.77¡0.29 3.06¡0.38
The times of sampling are presented as means¡standard deviation. Cortisol results are presented expressed as means¡
standard error, adjusted for age, gender, grade of employment, body mass index, smoking status, self-rated health, cardio-
vascular medication, depression and time of waking.
1820 A. Steptoe and othersﬂatter cortisol slopes [49, 50], while individuals who
utilize adaptive coping styles have steeper slopes [51].
By contrast, there was no association with peak cor-
tisol, suggesting that the diﬀerent components of the
cortisol diurnal rhythm have varying associations
with health-related biological processes. Previous
studies have shown limited associations between cor-
tisol slopes, peak levels, and average output [52].
The mechanisms underlying the association be-
tween pathogen burden and cortisol rhythm are not
certain. The eﬀect appeared to be driven primarily by
CMV seropositivity, although the signiﬁcant trend
across pathogen burden categories indicates that
C. pneumoniae and HSV-1 also contributed. There are
four broad possibilities. First, there could be a direct
eﬀect of pathogens on HPA function. Infection with
these common pathogens is likely to have taken
place early in life [19, 26, 53]. CMV is a potent im-
munomodulator [54], and is believed to contribute
to T-cell immunosenescence [55]. Viral infections
are associated with concomitant activation of the
HPA, and cytokines released in response to viral in-
fection induce corticotrophin-releasing factor (CRF),
have direct eﬀects on adrenocorticotropic hormone
(ACTH) release from the anterior pituitary, and pro-
mote glucocorticoid secretion from the adrenal glands
[56]. Levels of mRNA in the paraventricular nucleus
of the hypothalamus and the peptides corticotrophin-
releasing hormone and arginine vasopressin in the
median eminence are raised by endotoxin treatment in
early life, and may lead to resetting of adult HPA
function [57]. HSV-1 may cause down-regulation of
glucocorticoid receptors in the hippocampus, thereby
augmenting HPA activation [58]. These responses
could lead to chronic HPA dysregulation expressed as
a ﬂattened diurnal cortisol proﬁle, although direct
mechanistic evidence is currently lacking.
A second possibility is that disturbed cortisol pro-
ﬁles may have preceded infection and increased
susceptibility. Even though cortisol was assessed in
middle-age whereas infection was probably acquired
early in life, the temporal relationship between
infection and cortisol cannot be determined in this
cross-sectional design. However, administration of
glucocorticoids to human cell cultures enhances the
growth and replication of CMV and C. pneumoniae
[37, 38]. Third, exposure to infection in childhood and
psychosocial adversity may coexist. Acquisition of a
variety of pathogens early in life is greater in children
from low SES backgrounds [19, 22, 59], and living
in poorer, crowded residences may increase risk of
family conﬂict and maltreatment [3]. These factors
can in turn stimulate HPA dysregulation that is
manifested in adult life [13, 14]. If this is the case, then
infectious burden could be a marker of stressful ex-
periences in early life that lead to HPA dysfunction,
andhavenodirectrole.Interestingly,otherpopulation
studies have shown diﬀerential associations between
childhood SES and diﬀerent measures of cortisol
rhythm in adult life, consistent with the current ﬁnd-
ings [12].
A fourth possibility is that the association is due to
stress-related increases in antibody titres for latent
infections. There is a growing literature relating anti-
body titres with psychological stress [60, 61], and evi-
dence that cortisol is involved in the up-regulation of
viral replication [62–64]. It has recently been shown
that HSV-1 antibody levels are heightened in ado-
lescents who experienced severe stress or abuse as chil-
dren [65]. It is theoretically possible that our results
were related to reactivation of pathogens, increasing
thelikelihoodthatantibodylevelsexceedthethreshold
for seropositivity tests. However, this is unlikely for
two reasons. First, the detection thresholds in the tests
for serostatus were set low. Second, we found no as-
sociation between cortisol and the levels of CMV or
HSV-1 antibodies in analyses limited to individuals
who had positive serostatus (results not presented).
This study has several limitations. The sample
was weighted towards men, as is also the case in the
larger Whitehall study from which participants were
drawn [43]. We have no evidence about when sero-
positivity for these infectious agents was acquired. We
only tested three pathogens, and other organisms
0123
Pathogen burden
0·00
0·50
1·00
1·50
2·00
C
o
r
t
i
s
o
l
 
d
e
c
l
i
n
e
 
(
n
m
o
l
/
l
 
p
e
r
 
h
)
Fig. 2. Mean rate of salivary cortisol decrease over the day
in participants with infectious burden scores of 0, 1, 2 or 3.
The diﬀerence was signiﬁcant after adjustment for age,
gender, grade of employment, body mass index, smoking
status, self-rated health, cardiovascular medication, de-
pressive symptoms and time of waking in the morning.
Error bars are S.E.M.
Cortisol and infectious burden 1821are relevant to pathologies such as CHD, notably
periodontal infectious agents [66]. Multiple days of
cortisol monitoring would have been desirable, since
measures from a single day may not be representative
[67]. Despite adjusting statistically for the principle
inﬂuences on cortisol regulation, unmeasured factors
correlated with infection exposure may have aﬀected
cortisol output. We were not able to measure ACTH
in our study, and this would have been valuable for
the understanding of cortisol dynamics. Nor was it
possible to conclude whether overall exposure to
cortisol throughout the complete diurnal cycle dif-
fered between pathogen burden groups, since values
were not recorded in the night. Nevertheless, this
study on a large well characterized population sug-
gests that cumulative pathogen burden is positively
related to cortisol dysregulation. Since early life psy-
chosocial adversity frequently coincides with patho-
gen exposure, this association may be relevant to the
processes through which life experience aﬀects HPA
function in health and disease.
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